Literature DB >> 4053267

A low density lipoprotein-methotrexate covalent complex and its activity against L1210 cells in vitro.

G W Halbert, J F Stuart, A T Florence.   

Abstract

Low-density lipoprotein particles are potential drug carriers, but only lipophilic drug species partition into the core of the system. In this paper the polar drug methotrexate has been coupled to the exterior protein of low density lipoprotein (LDL) particles using the reagent 1-ethyl-3(3'-dimethylaminopropyl) carbodiimide HCl. The coupled system was sized by photon correlation spectroscopy and the in vitro activity of the complex determined against L1210 cells maintained in medium supplemented with fetal calf serum. The reaction between methotrexate and low density lipoprotein is variable but quantifiable, about ten drug molecules being attached to each LDL particle, resulting in an increase in the radius and polydispersity of the particles. The activity of the complex against L1210 murine leukaemia cells has been demonstrated in vitro, but it is 30 times less active than free drug.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4053267     DOI: 10.1007/BF00263890

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  21 in total

1.  Melanotropin-daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells.

Authors:  J M Varga; N Asato; S Lande; A B Lerner
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

2.  Preparation and properties of serum and plasma proteins; the refractive properties of the proteins of human plasma and certain purified fractions.

Authors:  S H ARMSTRONG; M J E BUDKA
Journal:  J Am Chem Soc       Date:  1947-07       Impact factor: 15.419

3.  Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation.

Authors:  J R Patsch; S Sailer; G Kostner; F Sandhofer; A Holasek; H Braunsteiner
Journal:  J Lipid Res       Date:  1974-07       Impact factor: 5.922

4.  Interactions of ionic and non-ionic surfactants with plasma low density lipoprotein.

Authors:  I G Tucker; A T Florence
Journal:  J Pharm Pharmacol       Date:  1983-11       Impact factor: 3.765

Review 5.  Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents.

Authors:  R E Counsell; R C Pohland
Journal:  J Med Chem       Date:  1982-10       Impact factor: 7.446

6.  Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism.

Authors:  D Gal; P C MacDonald; J C Porter; E R Simpson
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

7.  Targeted killing of cultured cells by receptor-dependent photosensitization.

Authors:  S T Mosley; J L Goldstein; M S Brown; J R Falck; R G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

8.  Delivery of aclacinomycin A to human glioma cells in vitro by the low-density lipoprotein pathway.

Authors:  M J Rudling; V P Collins; C O Peterson
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

9.  Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms.

Authors:  D Gal; M Ohashi; P C MacDonald; H J Buchsbaum; E R Simpson
Journal:  Am J Obstet Gynecol       Date:  1981-04-15       Impact factor: 8.661

10.  Effect of cell density on binding and uptake of low density lipoprotein by human fibroblasts.

Authors:  H S Kruth; J Avigan; W Gamble; M Vaughan
Journal:  J Cell Biol       Date:  1979-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.